ORG Partners LLC lowered its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 45.3% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,170 shares of the healthcare conglomerate's stock after selling 969 shares during the quarter. ORG Partners LLC's holdings in UnitedHealth Group were worth $665,000 as of its most recent SEC filing.
Several other hedge funds have also recently made changes to their positions in the business. Capital & Planning LLC raised its stake in UnitedHealth Group by 19.2% during the 4th quarter. Capital & Planning LLC now owns 491 shares of the healthcare conglomerate's stock worth $248,000 after buying an additional 79 shares during the period. Brighton Jones LLC grew its position in UnitedHealth Group by 176.2% in the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate's stock valued at $22,384,000 after purchasing an additional 28,231 shares during the period. Union Bancaire Privee UBP SA acquired a new position in UnitedHealth Group during the fourth quarter worth $27,233,000. Revolve Wealth Partners LLC grew its holdings in shares of UnitedHealth Group by 137.1% during the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate's stock valued at $2,033,000 after buying an additional 2,324 shares during the last quarter. Finally, Bank Pictet & Cie Europe AG increased its position in shares of UnitedHealth Group by 3.9% during the fourth quarter. Bank Pictet & Cie Europe AG now owns 263,655 shares of the healthcare conglomerate's stock worth $133,373,000 after acquiring an additional 9,872 shares in the last quarter. 87.86% of the stock is owned by institutional investors.
UnitedHealth Group Stock Performance
Shares of UNH opened at $306.90 on Friday. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.85 and a current ratio of 0.85. The stock has a market capitalization of $278.40 billion, a price-to-earnings ratio of 12.85, a price-to-earnings-growth ratio of 1.44 and a beta of 0.44. UnitedHealth Group Incorporated has a 52-week low of $248.88 and a 52-week high of $630.73. The stock's 50-day simple moving average is $365.09 and its 200 day simple moving average is $465.88.
UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). The firm had revenue of $109.58 billion for the quarter, compared to analysts' expectations of $111.56 billion. UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. During the same period in the prior year, the firm posted $6.91 EPS. Research analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.
UnitedHealth Group Increases Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th will be issued a dividend of $2.21 per share. This is a positive change from UnitedHealth Group's previous quarterly dividend of $2.10. The ex-dividend date is Monday, June 16th. This represents a $8.84 annualized dividend and a dividend yield of 2.88%. UnitedHealth Group's payout ratio is presently 37.02%.
Insider Buying and Selling
In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 589 shares of the firm's stock in a transaction on Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total transaction of $179,645.00. Following the completion of the transaction, the chief executive officer now owns 10,398 shares of the company's stock, valued at approximately $3,171,390. This trade represents a 5.36% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Timothy Patrick Flynn bought 1,533 shares of the firm's stock in a transaction on Wednesday, May 14th. The stock was purchased at an average cost of $320.80 per share, with a total value of $491,786.40. Following the completion of the acquisition, the director now directly owns 6,033 shares of the company's stock, valued at approximately $1,935,386.40. The trade was a 34.07% increase in their position. The disclosure for this purchase can be found here. Insiders have purchased a total of 109,408 shares of company stock worth $31,607,768 in the last ninety days. 0.28% of the stock is owned by insiders.
Analysts Set New Price Targets
A number of analysts have commented on UNH shares. Morgan Stanley decreased their price objective on UnitedHealth Group from $563.00 to $374.00 and set an "overweight" rating for the company in a report on Wednesday, May 14th. Hsbc Global Res lowered UnitedHealth Group from a "hold" rating to a "moderate sell" rating in a research report on Wednesday, May 21st. Royal Bank Of Canada cut their price objective on shares of UnitedHealth Group from $525.00 to $355.00 and set an "outperform" rating on the stock in a report on Friday, May 16th. Mizuho reduced their price objective on shares of UnitedHealth Group from $515.00 to $350.00 and set an "outperform" rating for the company in a research report on Friday, May 16th. Finally, Baird R W downgraded UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, June 11th. One research analyst has rated the stock with a sell rating, nine have given a hold rating and sixteen have assigned a buy rating to the company's stock. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $426.52.
Read Our Latest Research Report on UNH
UnitedHealth Group Company Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report